Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001904824-26-000002

Options or other derivatives

  • Chief Scientific Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smeal Tod Chief Scientific Officer 2026-04-14 Grant or award · Stock Options +300,000 1,279,805 D
Loading xslF345X06/ownership.xml…